High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P <sub>3</sub> Lysophospholipid ReceptorGregor Theilmeier, Bodo Levkau, Otmar Schober et al.|Circulation|2006Cited by 413
Sphingosine-1-Phosphate Stimulates the Functional Capacity of Progenitor Cells by Activation of the CXCR <sub>4</sub> -Dependent Signaling Pathway via the S1P <sub>3</sub> ReceptorDirk Walter, Judith Haendeler, Ulrich Rochwalsky et al.|Arteriosclerosis Thrombosis and Vascular Biology|2006Cited by 161
HDL-Associated Lysosphingolipids Inhibit NAD(P)H Oxidase-Dependent Monocyte Chemoattractant Protein-1 ProductionMarkus Tölle, Jerzy–Roch Nofer, Alicja Pawlak et al.|Arteriosclerosis Thrombosis and Vascular Biology|2008Cited by 153
Immunomodulator FTY720 Induces eNOS-Dependent Arterial Vasodilatation via the Lysophospholipid Receptor S1P <sub>3</sub>Markus Tölle, Markus van der Giet, Bodo Levkau et al.|Circulation Research|2005Cited by 123
Sphingosine‐1‐Phosphate Receptor 1 Regulates Cardiac Function by Modulating Ca <sup>2+</sup> Sensitivity and Na <sup>+</sup> /H <sup>+</sup> Exchange and Mediates Protection by Ischemic PreconditioningPetra Keul, Bodo Levkau, Marcel M. G. J. van Borren et al.|Journal of the American Heart Association|2016Cited by 64